Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Dermatology
»
Psoriasis
11. August 2026
Search
medline.ch
Psoriasis
Advanced search
Dermatology
Acne
Alopecia
Dermatitis
Infectious Skin Diseases
Photosensitivity Disorder
Psoriasis
Skin Neoplasms
Skin Ulcer
Urticaria
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 1419
Articles 1 - 20 / 28372
Efficacy and safety of Janus kinase and TYK2 inhibitors in the treatment of generalized pustular psoriasis and palmoplantar pustulosis: a systematic review.
Immunol Res
Rasouli A, Heidari N, Heidari A, Khalifezadeh M, Goodarzi A.
PMID: 42573865 [PubMed - indexed for MEDLINE]
Targeted therapies for psoriasis and atopic dermatitis in the context of malignancy: SPIN-FRT recommendations.
J Eur Acad Dermatol Venereol
Torres T, Brembilla NC, King B, Chovatiya R, Warren RB, Flohr C, Vestergaard C, Irvine AD, Carrascosa JM, Maul JT, Smith CH, Langley RG, Cortés J, Sibaud V, Thaçi D, Boehncke WH, Spuls P, Puig L.
PMID: 42573454 [PubMed - as supplied by publisher]
IL-17 at the eye - joint interface in psoriatic disease: mechanisms, clinical correlates, and therapeutic implications.
Expert Rev Clin Immunol
Troisi M, Troisi S, Costa L, Ruscitti P, Maione F, Costagliola C, Giacomelli R, Cantarini L, Fabiani C, Caso F.
PMID: 42573121 [PubMed - as supplied by publisher]
Patients' and clinicians' perspectives on telemedicine to monitor patients on systemic treatment for psoriasis or atopic dermatitis - a mixed methods study.
J Dermatolog Treat
Henckens NFT, Pawlak ME, Wanten SAC, Weng YC, V Ee I, Arents BWM, Witkamp L, de Bruin-Weller MS, Baerveldt EM, Seyger MMB, de Jong EMGJ, van Enst WA, van den Reek JMPA.
PMID: 42573065 [PubMed - indexed for MEDLINE]
Prevalence of periapical abscesses in psoriasis patients: a retrospective cross-sectional study.
Restor Dent Endod
Rotstein I, Katz J, Grandini S, Malvicini G, Garcia-Godoy F.
PMID: 42572507 [PubMed - as supplied by publisher]
Current insights into the metabolic dysregulation of keratinocytes in psoriasis: A review.
J Dermatol Sci
He J, Liu C, Li J, Li L, Li H.
PMID: 42570894 [PubMed - as supplied by publisher]
The Efficacy of Oral Icotrokinra versus Injectable IL-23 Inhibitors for Moderate-to-Severe Plaque Psoriasis: A Comparative Meta-Analysis.
J Am Acad Dermatol
Gupta S, Amoyaw B, Xiong G, Abu-Hilal M.
PMID: 42570846 [PubMed - as supplied by publisher]
Effect of apremilast on entheseal bone damage in psoriasis patients at risk of developing psoriatic arthritis - data from the prospective, interventional EPOS study.
Arthritis Res Ther
Simon D, Minopoulou I, Bayat S, Schuster L, Tascilar K, Roemer F, Mutlu MY, Rech J, Werner D, Krönke G, Fagni F, Sticherling M, Schett G, Kleyer A.
PMID: 42568089 [PubMed - indexed for MEDLINE]
Mechanistic insight into Solanum lyratum Thunb. extract for ameliorating imiquimod-induced psoriasis in mice via suppression of mast cell and Th17 cell response.
Fitoterapia
Jin S, Chen J, He Y, Guo Y, Zhang J, Zhang Z, Ye F, Chen G.
PMID: 42551598 [PubMed - as supplied by publisher]
Comparison of clinical and dermoscopical nail findings of rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and psoriasis: A prospective study.
Medicine (Baltimore)
Güne, Yurdakul OV, Tak AY, Yilmaz N, Küçük ÖS, Onsun N.
PMID: 42566593 [PubMed - indexed for MEDLINE]
CRP at diagnosis in psoriatic arthritis: what it means and associations with long-term outcomes.
Rheumatology (Oxford)
Dimopoulou AE, Papagoras C, Kyriazi N, Gazi S, Mole E, Krikelis M, Voulgari PV, Kaltsonoudis E, Koletsos N, Katsimpri P, Boumpas D, Katsifis-Nezis D, Kougkas N, Dimitroulas T, Sfikakis PP, Tektonidou MG, Vassilakis KD, Bogdanos D, Simopoulou T, Koutsianas C, Mavrea E, Katsifis G, Kottas K, Konsta M, Tziafalia M, Kataxaki E, Kalavri E, Klavdianou K, Karamanakos A, Xynogalas I, Daoussis D, Iliopoulos G, Bournazos I, Georganas K, Patrikos D, Vassilopoulos D, Fragoulis GE.
PMID: 42565545 [PubMed - as supplied by publisher]
Long-term risk of incident psoriasis in patients with irritable bowel syndrome: a large-scale prospective cohort study.
J Glob Health
Qiu Y, Zhou Y, Liu S, Zhang Q, Zhang S, Wu J, Zhu S, Wu S.
PMID: 42565434 [PubMed - indexed for MEDLINE]
Clinical characteristics and outcomes of paradoxical palmoplantar pustulosis during secukinumab therapy in biologic-naïve patients with plaque psoriasis: a retrospective case series.
J Dermatolog Treat
Si Q, Zhang Y, Li J, Zhu N, Li Z, Yan H, Wu R, He X, Liu L, Mu Q.
PMID: 42565330 [PubMed - indexed for MEDLINE]
Global health and economic impact of expanding the WHO essential medicines list for psoriasis: a health economic modelling study.
EClinicalMedicine
Ali F, Wright AK, Graier T, El Sayed M, Giles RH, Lambert J, French LE, Lim HW, Ashcroft DM, C M van de Kerkhof P, Griffiths CEM, Gavan SP, Lwin SM.
PMID: 42564855 [PubMed]
Efficacy and safety of interleukin inhibitors in the treatment of moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis.
Front Med (Lausanne)
Ming J, Jiang Y, Wu Q, Xiao X, Chen M.
PMID: 42564794 [PubMed]
Post-transcriptional regulation via alternative polyadenylation and piRNA shapes macrophage responses in psoriasis.
Front Immunol
Lin B, Du X, Lu L, Wang Z, Zhao Y, Feng Y, Liu L.
PMID: 42564021 [PubMed - indexed for MEDLINE]
Durability of response to Icotrokinra in the ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 Trials: a potential new novel oral treatment for psoriasis.
Br J Dermatol
Millette D.
PMID: 42563545 [PubMed - as supplied by publisher]
Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.
Am J Clin Dermatol
Armstrong AW, Lebwohl M, Warren RB, Morita A, Paul C, Thaçi D, Augustin M, Puig L, Daamen C, Li J, Alió A, Aggrey-Amable A, Scotto J, Popmihajlov Z, Vaile J, Strober B.
PMID: 42563042 [PubMed - as supplied by publisher]
Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with active psoriatic arthritis: 52-week results from the randomised, double-blind, placebo-controlled phase 3 POETYK PsA-1 trial.
Ann Rheum Dis
van der Heijde D, Mease PJ, Paul C, Behrens F, Gossec L, Kaneko Y, Eder L, Coates LC, Pink AE, Wan W, Soriano ER, Leszczy, Scher JU, Deodhar A, Pachai C, Li J, Fan X, Rabbat S, Sardinas C, Vritzali E, Vaile J, Merola JF.
PMID: 42562758 [PubMed - as supplied by publisher]
Injection Site Pain Levels with Biologic Medications for Atopic Dermatitis and Psoriasis: A Real-Life Study.
J Am Acad Dermatol
Karpoff K, Lau WC, Lebwohl M.
PMID: 42562102 [PubMed - as supplied by publisher]
Articles 1 - 20 / 28372
Page 1 of 1419
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy